Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

NCT ID: NCT01336205

Last Updated: 2014-10-20

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

844 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-04-30

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the long-term safety and tolerability of NKTR-118 treatment of opioid-induced constipation (OIC) in patients with non-cancer-related pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioid-Induced Constipation (OIC)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Oral Treatment

Group Type EXPERIMENTAL

NKTR-118

Intervention Type DRUG

25 mg oral tablet once daily

2

Oral treatment

Group Type ACTIVE_COMPARATOR

Usual care

Intervention Type DRUG

As prescribed by the investigator

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NKTR-118

25 mg oral tablet once daily

Intervention Type DRUG

Usual care

As prescribed by the investigator

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Provision of written informed consent prior to any study-specific procedures.
* NEW PATIENTS ONLY: Self-reported active symptoms of OIC at screening (\<3 SBMs/week and experiencing \>1 reported symptom of hard/lumpy stools, straining, or sensation of incomplete evacuation/anorectal obstruction in at least 25% of the BMs over the previous 4 weeks); and Documented confirmed OIC (\<3 SBMs/week on average over the 2-week OIC confirmation period.
* PATIENTS ENROLLING FROM OTHER NKTR-118 STUDIES: Receiving a stable maintenance opioid regimen consisting of a total daily dose of 30 mg to 1000 mg or oral morphine, or equianalgesic amount(s) of 1 or more opioid therapies.
* FOR PATIENTS RANDOMIZED TO RECEIVE NKTR-118: Willingness to stop all laxatives and other bowel regimens including prune juice and herbal products throughout the 52-week treatment period, and to use only bisacodyl as rescue medication if BM has not occurred within at least 72 hours of the last recorded BM.

Exclusion Criteria

* Patients receiving Opioid regimen for treatment of pain related to cancer.
* History of cancer within 5 years from first study visit with the exception of basal cell cancer and squamous cell skin cancer.
* Medical conditions and treatments associated with diarrhea, intermittent loose stools, or constipation.
* Other issues related to the gastrointestinal tract that could impose a risk to the patient.
* Pregnancy or lactation.
Minimum Eligible Age

18 Years

Maximum Eligible Age

84 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mark Sostek

Role: STUDY_DIRECTOR

AstraZeneca

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Athens, Alabama, United States

Site Status

Research Site

Birmingham, Alabama, United States

Site Status

Research Site

Huntsville, Alabama, United States

Site Status

Research Site

Mobile, Alabama, United States

Site Status

Research Site

Pell City, Alabama, United States

Site Status

Research Site

Garden Grove, Arizona, United States

Site Status

Research Site

Goodyear, Arizona, United States

Site Status

Research Site

Mesa, Arizona, United States

Site Status

Research Site

Phoenix, Arizona, United States

Site Status

Research Site

Tucson, Arizona, United States

Site Status

Research Site

Tuscon, Arizona, United States

Site Status

Research Site

Jonesboro, Arkansas, United States

Site Status

Research Site

Little Rock, Arkansas, United States

Site Status

Research Site

North Little Rock, Arkansas, United States

Site Status

Research Site

Sherwood, Arkansas, United States

Site Status

Research Site

Arcadia, California, United States

Site Status

Research Site

Chino, California, United States

Site Status

Research Site

Encino, California, United States

Site Status

Research Site

Fremont, California, United States

Site Status

Research Site

Garden Grove, California, United States

Site Status

Research Site

Huntington Park, California, United States

Site Status

Research Site

La Mesa, California, United States

Site Status

Research Site

Laguna Hills, California, United States

Site Status

Research Site

Lakewood, California, United States

Site Status

Research Site

Long Beach, California, United States

Site Status

Research Site

Oceanside, California, United States

Site Status

Research Site

Orange, California, United States

Site Status

Research Site

Pasadena, California, United States

Site Status

Research Site

Riverside, California, United States

Site Status

Research Site

San Bernardino, California, United States

Site Status

Research Site

San Diego, California, United States

Site Status

Research Site

San Francisco, California, United States

Site Status

Research Site

Santa Ana, California, United States

Site Status

Research Site

Walnut Creek, California, United States

Site Status

Research Site

Whittier, California, United States

Site Status

Research Site

Colorado Springs, Colorado, United States

Site Status

Research Site

Stamford, Connecticut, United States

Site Status

Research Site

Boynton Beach, Florida, United States

Site Status

Research Site

Bradenton, Florida, United States

Site Status

Research Site

Brooksville, Florida, United States

Site Status

Research Site

Chiefland, Florida, United States

Site Status

Research Site

Clearwater, Florida, United States

Site Status

Research Site

Crystal River, Florida, United States

Site Status

Research Site

Daytona Beach, Florida, United States

Site Status

Research Site

DeBary, Florida, United States

Site Status

Research Site

Deerfield Beach, Florida, United States

Site Status

Research Site

Delray Beach, Florida, United States

Site Status

Research Site

Edgewater, Florida, United States

Site Status

Research Site

Eustis, Florida, United States

Site Status

Research Site

Fort Myers, Florida, United States

Site Status

Research Site

Inverness, Florida, United States

Site Status

Research Site

Jacksonville, Florida, United States

Site Status

Research Site

Jackson, Florida, United States

Site Status

Research Site

Jupiter, Florida, United States

Site Status

Research Site

Largo, Florida, United States

Site Status

Research Site

Lauderhill, Florida, United States

Site Status

Research Site

Miami, Florida, United States

Site Status

Research Site

Naples, Florida, United States

Site Status

Research Site

North Miami, Florida, United States

Site Status

Research Site

Ocala, Florida, United States

Site Status

Research Site

Orange City, Florida, United States

Site Status

Research Site

Orlando, Florida, United States

Site Status

Research Site

Oviedo, Florida, United States

Site Status

Research Site

Pembroke Pines, Florida, United States

Site Status

Research Site

Pinellas Park, Florida, United States

Site Status

Research Site

Plantation, Florida, United States

Site Status

Research Site

Port Orange, Florida, United States

Site Status

Research Site

Port Saint Lucie, Florida, United States

Site Status

Research Site

Saint Doral, Florida, United States

Site Status

Research Site

South Miami, Florida, United States

Site Status

Research Site

St. Petersburg, Florida, United States

Site Status

Research Site

Tamarac, Florida, United States

Site Status

Research Site

Tampa, Florida, United States

Site Status

Research Site

West Palm Beach, Florida, United States

Site Status

Research Site

West Palm, Florida, United States

Site Status

Research Site

Winter Park, Florida, United States

Site Status

Research Site

Alpharetta, Georgia, United States

Site Status

Research Site

Atlanta, Georgia, United States

Site Status

Research Site

Columbus, Georgia, United States

Site Status

Research Site

Marietta, Georgia, United States

Site Status

Research Site

Suwanee, Georgia, United States

Site Status

Research Site

Tucker, Georgia, United States

Site Status

Research Site

Boise, Idaho, United States

Site Status

Research Site

Bloomington, Illinois, United States

Site Status

Research Site

Chicago, Illinois, United States

Site Status

Research Site

Peoria, Illinois, United States

Site Status

Research Site

Schaumburg, Illinois, United States

Site Status

Research Site

Evansville, Indiana, United States

Site Status

Research Site

Indianapolis, Indiana, United States

Site Status

Research Site

Council Bluffs, Iowa, United States

Site Status

Research Site

Kansas City, Kansas, United States

Site Status

Research Site

Lansing, Kansas, United States

Site Status

Research Site

Overland Park, Kansas, United States

Site Status

Research Site

Wichita, Kansas, United States

Site Status

Research Site

Louisville, Kentucky, United States

Site Status

Research Site

New Orleans, Louisiana, United States

Site Status

Research Site

Shreveport, Louisiana, United States

Site Status

Research Site

Baltimore, Maryland, United States

Site Status

Research Site

Columbia, Maryland, United States

Site Status

Research Site

Hollywood, Maryland, United States

Site Status

Research Site

Pikesville, Maryland, United States

Site Status

Research Site

Reisterstown, Maryland, United States

Site Status

Research Site

Watertown, Massachusetts, United States

Site Status

Research Site

Calamazoo, Michigan, United States

Site Status

Research Site

Traverse City, Michigan, United States

Site Status

Research Site

St Louis, Missouri, United States

Site Status

Research Site

Bellevue, Nebraska, United States

Site Status

Research Site

Fremont, Nebraska, United States

Site Status

Research Site

Lincoln, Nebraska, United States

Site Status

Research Site

Omaha, Nebraska, United States

Site Status

Research Site

Henderson, Nevada, United States

Site Status

Research Site

Las Vegas, Nevada, United States

Site Status

Research Site

Clifton, New Jersey, United States

Site Status

Research Site

Freehold, New Jersey, United States

Site Status

Research Site

Lumberton, New Jersey, United States

Site Status

Research Site

Toms River, New Jersey, United States

Site Status

Research Site

Voorhees Township, New Jersey, United States

Site Status

Research Site

Willingboro, New Jersey, United States

Site Status

Research Site

Albuquerque, New Mexico, United States

Site Status

Research Site

Great Neck, New York, United States

Site Status

Research Site

Hartsdale, New York, United States

Site Status

Research Site

New York, New York, United States

Site Status

Research Site

North Massapequa, New York, United States

Site Status

Research Site

Charlotte, North Carolina, United States

Site Status

Research Site

Elkin, North Carolina, United States

Site Status

Research Site

Flat Rock, North Carolina, United States

Site Status

Research Site

Harrisburg, North Carolina, United States

Site Status

Research Site

Mooresville, North Carolina, United States

Site Status

Research Site

Morganton, North Carolina, United States

Site Status

Research Site

Morrisville, North Carolina, United States

Site Status

Research Site

Winston-Salem, North Carolina, United States

Site Status

Research Site

Akron, Ohio, United States

Site Status

Research Site

Beavercreek, Ohio, United States

Site Status

Research Site

Centerville, Ohio, United States

Site Status

Research Site

Toledo, Ohio, United States

Site Status

Research Site

Oklahoma City, Oklahoma, United States

Site Status

Research Site

Downingtown, Pennsylvania, United States

Site Status

Research Site

Jenkintown, Pennsylvania, United States

Site Status

Research Site

Norristown, Pennsylvania, United States

Site Status

Research Site

Philadelphia, Pennsylvania, United States

Site Status

Research Site

Pottstown, Pennsylvania, United States

Site Status

Research Site

Anderson, South Carolina, United States

Site Status

Research Site

Charleston, South Carolina, United States

Site Status

Research Site

Greer, South Carolina, United States

Site Status

Research Site

Myrtle Beach, South Carolina, United States

Site Status

Research Site

Chattanooga, Tennessee, United States

Site Status

Research Site

Clarksville, Tennessee, United States

Site Status

Research Site

Jackson, Tennessee, United States

Site Status

Research Site

Memphis, Tennessee, United States

Site Status

Research Site

Milan, Tennessee, United States

Site Status

Research Site

New Tazewell, Tennessee, United States

Site Status

Research Site

Austin, Texas, United States

Site Status

Research Site

Dallas, Texas, United States

Site Status

Research Site

Houston, Texas, United States

Site Status

Research Site

Hurst, Texas, United States

Site Status

Research Site

Lexington, Texas, United States

Site Status

Research Site

Marshall, Texas, United States

Site Status

Research Site

San Antonio, Texas, United States

Site Status

Research Site

Sugarland, Texas, United States

Site Status

Research Site

Victoria, Texas, United States

Site Status

Research Site

Clinton, Utah, United States

Site Status

Research Site

Ogden, Utah, United States

Site Status

Research Site

Salt Lake City, Utah, United States

Site Status

Research Site

St. George, Utah, United States

Site Status

Research Site

West Jordan, Utah, United States

Site Status

Research Site

Richmond, Virginia, United States

Site Status

Research Site

Springfield, Virginia, United States

Site Status

Research Site

Virginia Beach, Virginia, United States

Site Status

Research Site

Middleton, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Webster L, Chey WD, Tack J, Lappalainen J, Diva U, Sostek M. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation. Aliment Pharmacol Ther. 2014 Oct;40(7):771-9. doi: 10.1111/apt.12899. Epub 2014 Aug 12.

Reference Type DERIVED
PMID: 25112584 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

D3820C00008

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Long Term Safety of Naldemedine
NCT01965652 COMPLETED PHASE3
Naloxegol US PMR CV Safety.
NCT02813356 UNKNOWN